Our Mission

Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.

Investor Relations

1
2

Events & Webcasts | Past Events

2019

Event
San Antonio Breast Cancer Symposium
Type
Scientific Conference
Date
December 10 - 14, 2019
Location
San Antonio, Texas
Download
Dec. 11: SUMMIT “basket” TRIAL Poster
Dec. 11: plasmaMATCH TRIAL Poster
Dec. 12: NALA, NEfERT-T, TBCRC-022 TRIALs Poster
Dec. 13: CONTROL TRIAL Poster
Event
Credit Suisse 28th Annual Healthcare Conference
Type
Investment Conference
Date
November 12, 2019
Time
10:55 a.m. MST (9:55 a.m. PST, 12:55 p.m. EST)
Webcast
N/A
Location
The Phoenician Resort, Scottsdale, AZ
Event
Puma Biotechnology 3Q-2019 Financial Results Conference Call
Type
Conference Call
Date
November 6, 2019
Time
1:30 p.m. PST/4:30 p.m. EST
Webcast
N/A
Download
Puma Biotechnology 3Q-2019 Results Call – SUMMIT Update
Puma Biotechnology 3Q-2019 Results Call – Commercial Update
Event
Cantor Global Healthcare Conference
Type
Investment Conference, Virtual
Date
October 3, 2019
Time
2:25 p.m. EDT
Location
InterContinental New York Barclay Hotel
Webcast
N/A
Event
H.C. Wainwright 21st Annual Global Investment Conference
Type
Investment Conference
Date
September 10, 2019
Time
9:35 a.m. EDT
Location
Lotte New York Palace Hotel, New York City
Webcast
N/A
Event
Citi’s 14th Annual Biotech Conference
Type
Investment Conference
Date
September 5, 2019
Location
Boston, MA
Event
Puma Biotechnology 2Q-2019 Financial Results Conference Call
Type
Conference Call
Date
August 8, 2019
Time
1:30 p.m. PDT/4:30 p.m. EDT
Webcast
N/A
Download
Puma Biotechnology 2Q–2019 Results Call – Commercial Update
Event
ESMO 21st World Congress on Gastrointestinal Cancer 2019
Type
Scientific Conference
Date
July 3--6, 2019
Location
Barcelona, Spain
Webcast
N/A
Download
July 3, 2019 -- ESMO GI Puma Slides
July 4, 2019 – ESMO GI Puma Poster
Event
Jefferies 2019 Global Healthcare Conference
Type
Investment Conference
Date
June 6, 2019
Time
3:30 p.m. EDT
Webcast
N/A
Event
ASCO 2019 Annual Meeting
Type
Scientific Conference
Date
May 31 – June 4, 2019
Location
Chicago, IL
Download
June 2, 2019 - ASCO 2019 - Puma CONTROL Poster
June 4 2019 ASCO 2019 Puma NALA Slides
Event
Bank of America Merrill Lynch Health Care Conference 2019
Type
Investment Conference
Date
May 15, 2019
Time
3:00 p.m. PDT
Location
Encore at the Wynn, Las Vegas
Event
Puma Biotechnology 1Q-2019 Financial Results Conference Call
Type
Conference Call
Date
May 9, 2019
Time
1:30 p.m. PDT/4:30 p.m. EDT
Webcast
N/A
Download
Puma Biotechnology 1Q–2019 Results Call – Commercial Update
Event
AACR Annual Meeting 2019
Type
Scientific Conference
Date
March 29 – April 3, 2019
Location
Atlanta, Georgia
Webcast
N/A
Download
March 31, 2019 – Abstract 1724 (Oral): Natural history and clinical characteristics of ERBB2 mutant hormone receptor-positive breast cancers: Results from the AACR Project GENIE Registry.
Michele LeNoue-Newton et al, Vanderbilt-Ingram Cancer Center, TN.
March 31, 2019 – Abstract 929 (Oral): Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple ontarget resistance mechanisms: Results from the SUMMIT ‘Basket’ TRIAL.
Helen H. Won et al, Memorial Sloan Kettering Cancer Center, New York
March 31, 2019 – Abstract 328 (Poster): ADAM17-induced activation of HER receptors mediate resistance to trastuzumab in a subset of moderate HER2-expressing breast cancer cells.
Katharina Feldinger et al, University of Birmingham, UK.
March 31, 2019 – Abstract 329 (Poster): Hyperactivation of mTORC1 drives acquired resistance to the pan-HER tyrosine kinase inhibitor neratinib in HER2-mutant cancers.
Dhivya R. Sudhan et al, UT Southwestern Medical Center, Dallas, TX.
March 31, 2019 – Abstract 389 (Poster): Role of HER3 signaling pathways in ER+ and HER2+ breast cancers.
Rosalin Mishra et al, University of Cincinnati College of Pharmacy, Cincinnati, OH.
March 31, 2019 – Abstract 395 (Poster): Aberrant HER2 signaling is a therapeutic target in a subset of castration-resistant prostate cancer.
Joshua W. Russo et al, Beth Israel Deaconess Medical Center, Boston, MA.
April 1, 2019 – Abstract 1923 (Poster): KRAS-mutant (mt) colorectal cancer (CRC) organoid models generated from patient-derived xenografts (PDX) show response to combination of trametinib (Tm), neratinib (N), and trastuzumab (Tz).
Rekha Pal et al, NSABP Foundation, Inc., Pittsburgh, PA.
April 2, 2019 – Abstract 4459 (Oral): Morphologic and genomic characterization of circulating tumor cells in patients with ERBB2 mutant HER2 non-amplified metastatic breast cancer treated with neratinib.
Stephanie Nicole Shishido et al, USC, Los Angeles.
April 2, 2019 – Abstract 4527 (Oral): Patient-derived organoids and xenografts identify neratinib plus HER2 antibody drug conjugate as a synergistic drug combination for HER2 mutated, non-amplified metastatic breast cancer.
Shunqiang Li et al, Washington University School of Medicine, Saint Louis, MO.
April 2, 2019 – Abstract 3705 (Poster): Identification of frequent HER2 activating mutations in canine primary pulmonary adenocarcinoma.
Gwendolen Lorch et al, Ohio State University College of Veterinary Med., Columbus, OH.
April 3, 2019 – Abstract 4827 (Poster): The therapeutic superiority of neratinib in combination with trastuzumab compared to pertuzumab plus trastuzumab in HER2-positive in vivo breast cancer models.
Jamunarani Veeraraghavan et al, Baylor College of Medicine, Houston, TX.
April 3, 2019 – Abstract 4832 (Poster): Preclinical evaluation of neratinib plus T-DM1 in orthotopic PDX models of HER2-positive breast cancer brain metastases.
Jing Ni et al, Dana Farber Cancer Institute, Boston, MA.
Event
Society of Gynecologic Oncology (SGO) 2019 Annual Meeting
Type
Scientific Conference
Date
March 16-19, 2019
Location
Honolulu, Hawaii
Download
Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT ‘basket’ TRIAL
Event
Cowen and Company 39th Annual Health Care Conference
Type
Investment Conference
Date
March 12, 2019
Time
10:00 a.m. EDT
Location
Boston Marriott Copley Place
Webcast
N/A
Event
Puma Biotechnology 4Q-2018 Financial Results Conference Call
Type
Conference Call
Date
February 28, 2019
Time
10:00 a.m. EDT
Location
1:30 p.m. PST/4:30 p.m. EST
Webcast
N/A
Download
Puma Biotechnology 4Q–2018 Results Call – Commercial Update
Event
Guggenheim Healthcare Talks Idea Forum | Oncology Day
Type
Investment Conference
Date
February 14, 2019
Location
The St. Regis New York
Event
J. P. Morgan 37th Annual Healthcare Conference
Type
Investment Conference
Date
January 9, 2019
Time
12:00 Noon PST
Location
Westin St. Francis Hotel, San Francisco, CA

Past Events and Webcasts by Year